Bard buys bulking agent from Genyx
This article was originally published in Clinica
Executive Summary
CR Bard has exercised its right to acquire a PMA-approved implantable bulking agent for the treatment of stress urinary incontinence. The Murray Hill, New Jersey firm intends to launch Uryx, which it acquired from Genyx Medical, in the first half of 2005. The polymer product is minimally invasively injected into the area around the urethra.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.